Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin D Hamilton

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
European Journal of Ophthalmology|April 29, 2022
Treatment of chronic diabetic macular oedema with intravitreal fluocinolone acetonide implant; real-life analysis of outcomes during overall treatment periodLaurence Cox, Yanda Li, Majid Fotuhi, et al.
Ophthalmology and Therapy|July 9, 2018
Three-Year Outcomes of Aflibercept Treatment for Neovascular Age-Related Macular Degeneration: Evidence from a Clinical SettingMaria Eleftheriadou, Maria Gemenetzi, Marko Lukic, et al.
Eye (London, England)|March 15, 2026
Clinical spectrum of intraocular inflammation following faricimab intravitreal injections: evidence from a large real-life cohort in the United KingdomGiuseppe Demarinis, Ian Yeung, Ella Preston, et al.
American Journal of Ophthalmology|December 28, 2016
ReplyMaria Eleftheriadou, Clara Vazquez-Alfageme, Cristina Maria Citu, et al.
American Journal of Ophthalmology|October 18, 2016
Long-Term Outcomes of Aflibercept Treatment for Neovascular Age-Related Macular Degeneration in a Clinical SettingMaria Eleftheriadou, Clara Vazquez-Alfageme, Cristina Maria Citu, et al.
The British Journal of Ophthalmology|April 21, 2026
Real-world early outcomes of intravitreal faricimab 6-mg and aflibercept 2-mg injection in diabetic macular oedemaEvangelia Chalkiadaki, Yue Sing Sim, Olayinka Williams, et al.
Eye (London, England)|June 26, 2021
Intravitreal injections: past trends and future projections within a UK tertiary hospitalReena Chopra, Gabriella C Preston, Tiarnan D L Keenan, et al.
Retina (Philadelphia, Pa.)|January 6, 2025
INTRAOCULAR INFLAMMATION ASSOCIATED WITH FARICIMAB THERAPY: One-Year Real-World OutcomesAndrea Montesel, Sagnik Sen, Ella Preston, et al.
Ophthalmology Science|January 8, 2024
Eccentric Viewing Training for Age-Related Macular Disease: Results of a Randomized Controlled Trial (the EFFECT Study)Gary S Rubin, Michael D Crossland, Hannah M P Dunbar, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|April 12, 2012
A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3Ranjan Rajendram, Samantha Fraser-Bell, Andrew Kaines, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
European Journal of Ophthalmology|April 29, 2022
Treatment of chronic diabetic macular oedema with intravitreal fluocinolone acetonide implant; real-life analysis of outcomes during overall treatment periodLaurence Cox, Yanda Li, Majid Fotuhi, et al.
Ophthalmology and Therapy|July 9, 2018
Three-Year Outcomes of Aflibercept Treatment for Neovascular Age-Related Macular Degeneration: Evidence from a Clinical SettingMaria Eleftheriadou, Maria Gemenetzi, Marko Lukic, et al.
Eye (London, England)|March 15, 2026
Clinical spectrum of intraocular inflammation following faricimab intravitreal injections: evidence from a large real-life cohort in the United KingdomGiuseppe Demarinis, Ian Yeung, Ella Preston, et al.
American Journal of Ophthalmology|December 28, 2016
ReplyMaria Eleftheriadou, Clara Vazquez-Alfageme, Cristina Maria Citu, et al.
American Journal of Ophthalmology|October 18, 2016
Long-Term Outcomes of Aflibercept Treatment for Neovascular Age-Related Macular Degeneration in a Clinical SettingMaria Eleftheriadou, Clara Vazquez-Alfageme, Cristina Maria Citu, et al.
The British Journal of Ophthalmology|April 21, 2026
Real-world early outcomes of intravitreal faricimab 6-mg and aflibercept 2-mg injection in diabetic macular oedemaEvangelia Chalkiadaki, Yue Sing Sim, Olayinka Williams, et al.
Eye (London, England)|June 26, 2021
Intravitreal injections: past trends and future projections within a UK tertiary hospitalReena Chopra, Gabriella C Preston, Tiarnan D L Keenan, et al.
Retina (Philadelphia, Pa.)|January 6, 2025
INTRAOCULAR INFLAMMATION ASSOCIATED WITH FARICIMAB THERAPY: One-Year Real-World OutcomesAndrea Montesel, Sagnik Sen, Ella Preston, et al.
Ophthalmology Science|January 8, 2024
Eccentric Viewing Training for Age-Related Macular Disease: Results of a Randomized Controlled Trial (the EFFECT Study)Gary S Rubin, Michael D Crossland, Hannah M P Dunbar, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|April 12, 2012
A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3Ranjan Rajendram, Samantha Fraser-Bell, Andrew Kaines, et al.
Pageof 3